These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3489670)

  • 1. Synergy between interleukin-2 and a second factor in the long-term growth of human T cells.
    Mills BJ; Shively JE; Mitsky PS; Hawke DH; Forman SJ; Wright CL; Todd CW
    Immunology; 1986 Sep; 59(1):57-61. PubMed ID: 3489670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR
    Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture.
    Neben S; Donaldson D; Sieff C; Mauch P; Bodine D; Ferrara J; Yetz-Aldape J; Turner K
    Exp Hematol; 1994 Apr; 22(4):353-9. PubMed ID: 8150033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.
    Thurman GB; Maluish AE; Rossio JL; Schlick E; Onozaki K; Talmadge JE; Procopio AD; Ortaldo JR; Ruscetti FW; Stevenson HC
    J Biol Response Mod; 1986 Feb; 5(1):85-107. PubMed ID: 3514800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early supernatants of mitogen-stimulated mononuclear cells promote long-term IL-2-dependent growth of human T lymphocytes.
    Siwicki JK; Steffen JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):109-17. PubMed ID: 8915514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of interleukins in the synergistic effect of B-cell mitogens with concanavalin A on hydrocortisone-resistant thymic cell proliferation.
    Nitta T; Konno-Ejiri H; Nemoto K; Okumura S; Ozawa A; Nakano M
    Immunology; 1986 Oct; 59(2):209-16. PubMed ID: 3490433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT; Grant AJ; Siegel JP
    J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor promoter teleocidin induces IL 2 receptor expression and IL 2-independent proliferation of human peripheral blood T cells.
    Isakov N; Bleackley RC; Shaw J; Altman A
    J Immunol; 1985 Oct; 135(4):2343-50. PubMed ID: 3928744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between IL-2 and human T cell colony formation.
    Mossalayi MD; Lecron JC; Tanzer J; Goube de Laforest P
    Clin Exp Immunol; 1986 Dec; 66(3):532-8. PubMed ID: 3494553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
    Cheever MA; Greenberg PD; Irle C; Thompson JA; Urdal DL; Mochizuki DY; Henney CS; Gillis S
    J Immunol; 1984 May; 132(5):2259-65. PubMed ID: 6609193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interleukin 4 promotes the growth of human T cells.
    Spits H; Yssel H; Takebe Y; Arai N; Yokota T; Lee F; Arai K; Banchereau J; de Vries JE
    J Immunol; 1987 Aug; 139(4):1142-7. PubMed ID: 3497196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
    J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
    Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
    Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.